Navigation Links
6th International Chronic Total Occlusion Summit to be held Feb. 5-6, 2009 in NYC
Date:1/7/2009

WHAT:
The Sixth International Chronic Total Occlusion (CTO) Summit is a two-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures that are essential for interventional cardiologists to optimize procedural success in chronic total coronary occlusions. The conference will include presentations from experts in the field, case review sessions, and numerous thematically organized live coronary CTO cases broadcast in high definition from Scripps Clinic and Research Foundation in La Jolla, CA, and Columbia Medical University in New York, NY.

WHY:
Chronic total occlusions (CTOs) of coronary arteries represent one of the greatest challenges to interventional cardiologists. Successful revascularization of CTOs has been strongly associated with improved left ventricular function, freedom from angina and future revascularization, and in several studies increased survival. Through new guidewires, novel devices, appropriate patient selection, and improved operator technique, the success rate for recanalization of complex CTOs is increasing. The novel retrograde approach to CTOs has been introduced as an alternative route for recanalization of otherwise difficult or impossible lesions.

Key topics will include:

  • CTO Revascularization: An Evidence Basis for Improving Clinical Outcomes
  • The CTO Toolbox: New and Imaginative Applications for Existing Technologies with Case-Based Presentations
  • Clinical Outcomes Following CTO Revascularization: A Global Perspective
  • Crossing Technique in CTO Revascularization (Antegrade and Retrograde)
  • CTO Complications
  • Solutions to the Last Great Barrier in PCI Success: Innovative Technologies

WHEN:
February 5 6, 2009

WHERE:
New York Marriott Marquis Hotel
New York, NY


'/>"/>

Contact: Judy Romero
jromero@crf.org
212-851-9311
Cardiovascular Research Foundation
Source:Eurekalert

Page: 1

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...ding will lead to treatments, , , FRIDA...y they,ve found a major cellular flaw that may dri...When caught early, lung cancer can often be treate...se is well advanced. Though doctors can sometimes ...prings back more virulent than ever, frequently sp...
(Date:7/3/2009)...ire-Asia/ -- Sundia MediTech, a leading,integrate...ompany in Shanghai,China announced today that Dr...ent of Chemistry Services. , Prior to joini...es, a drug,discovery and development company in S...t to Senior Director of Medicinal Chemistry of Neu...
(Date:7/3/2009)...panies and three individuals have been recognized ...tional competition designed to reward workplace he...tyXChange.org community released its 2009 Saxcies ...ww.safetyxchange.org/saxcies-video . The winners a...te their lives to keeping others safe - are detail...
(Date:7/3/2009)...Whitaker, MD, a founder of the alternative health ...ain.com, a new informational Web site devoted to a...tions. , Potomac, MD (Voc... of the alternative health movement, is now a feat...ional Web site devoted to all aspects of joint and...
Breaking Medicine News(10 mins):Health News:Cell Pathway May Be Key to Lung Cancer's Spread 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 3Health News:Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 3Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 4Health News:Dr. Julian Whitaker Featured on Searchjointpain.com 2
...of a recent study researchers say that the circadi...epeat in 24-hour cycles , can significantly impact...ercise // or receive medical treatments . During t...n 8:00 a.m. and 5:00 p.m were examined. Results f...
... the most common cancer among men, affecting about...d 220,000 new cases // of the disease are diagnose...te cancer every year. New research shows men who a...lining of their prostate ducts run a high risk of ...
...ws that people who suffer from sleep apnea run a h...sia administered // during surgery . Sleep apnea i...iodically during sleep . Statistics show the most ...obstructive sleep apnea, affects as many as 4 perc...
...a laugh signifies more than humor and ridicule, re...cal evidence // of the role of laughter during psy...e about communicating emotion than about humor. Re...s and took physiological measurements of both memb...
Other Medicine News:
(Date:6/29/2009)...for Novel Biotherapeutics Based On Naturally Resec...RNewswire/ -- Pangu BioPharma, a subsidiary of aTy...of its third patent application on proprietary, na.... Although tRNA synthetases are universal and ess...ound in all organisms, human synthetases have natu...
(Date:6/26/2009)...e 26, and OSAKA, Japan, June 27, 2009 /PRNewswire/...") today announced that Takeda Global Research &am... States (U.S.) subsidiary received on June 26 (U.S...ood and Drug Administration (FDA) regarding the Co... a selective dipeptidyl peptidase IV (DPP-4) inhib...
(Date:6/25/2009)...Medical Experts Slated to Attend First National Sy...re/ -- The first national symposium designed to ex...held next week in New York City when thirteen top ...om their respective fields. The SUNY Youth Sports... the health impacts that the $5 billion-a-year ene...
(Date:6/24/2009)...e 25 In a revolutionary healthcare... in the British Journal of Nutrition (a Cambridge...tics reduce cholesterol and triglycerides, contr..., The controlled clinical study was conducted on ...n 80% survival rate to 24 months versus a 50% surv...
Breaking Medicine Technology:Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 3Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes 2SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 2SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 3SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 4New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33% 2Education and progress at the 24th Annual EAU Congress in Stockholm 38671 1Education and progress at the 24th Annual EAU Congress in Stockholm 38671 2Stem cell breakthrough gives new hope to sufferers of muscle wasting diseases 7401 1Stem cell breakthrough gives new hope to sufferers of muscle wasting diseases 7401 2Magnetic nanoparticles navigate therapeutic genes through the body 7398 1NYU College of Dentistry awarded 241 9 million NIH grant for HIV research 7395 1NYU College of Dentistry awarded 241 9 million NIH grant for HIV research 7395 2
...2007 /PRNewswire-FirstCall/ --,Telik, Inc. announc... Phase 2 trial of the triplet combination of TELCY...paclitaxel will be,presented at the 98th annual me...rch (AACR) in Los Angeles. Preclinical studies of,...ancer cell growth,inhibition with TELCYTA in combi...
...2007 /PRNewswire-FirstCall/ --,Pharmacyclics, Inc....its novel histone deacetylase (HDAC) inhibitor and... presentations,will take place at the American Ass...eting being held April 14-18, 2007, at the Los,Ang... The presentations are as follows:, Sunday, A...
Other Medicine Technology:Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 2Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 3Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 2Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 3Pharmacyclics Announces Presentations on Its Novel and Selective,HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds 4
Liquichek Hematology-8 Control is a whole blood hematology control with extended stability for non-differential analyzers.
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays.
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays.
Built on the market leading optical performance of the OMEGA 180, the OMEGA 500 has been optimized for even better views of the fundus. A new multi-coated illumination system, including a new XHL Xen
Medicine Products: